Imprimis Pharma (IMMY) Reports Q4 Loss of $0.30
Imprimis Pharma (NASDAQ: IMMY) reported Q4 EPS of ($0.30), versus ($0.21) reported last year.
For earnings history and earnings-related data on Imprimis Pharma (IMMY) click here.
Imprimis Pharma (NASDAQ: IMMY) reported Q4 EPS of ($0.30), versus ($0.21) reported last year.
For earnings history and earnings-related data on Imprimis Pharma (IMMY) click here.